AN INTEGRATED PRECLINICAL EVALUATION OF DNA-REPAIR MECHANISMS IN DETERMINING RESPONSE TO PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) AS A GUIDE TO PATIENT SELECTION AND FOR DEVELOPMENT OF NOVEL COMBINATION THERAPIES